BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 17289476)

  • 1. Effect of polymer coating (poly 2-methoxyethylacrylate) of the oxygenator on hemostatic markers during cardiopulmonary bypass in children.
    Eisses MJ; Geiduschek JM; Jonmarker C; Cohen GA; Chandler WL
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):28-34. PubMed ID: 17289476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children.
    Eisses MJ; Chandler WL
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):53-9. PubMed ID: 18249331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
    Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
    Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of a silicone coated hollow fiber oxygenator.
    Shimono T; Shomura Y; Tani K; Shimamoto A; Hioki I; Tokui T; Onoda K; Takao M; Shimpo H; Yada I
    ASAIO J; 1997; 43(5):M735-9. PubMed ID: 9360143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.
    Chan AK; Leaker M; Burrows FA; Williams WG; Gruenwald CE; Whyte L; Adams M; Brooker LA; Adams H; Mitchell L; Andrew M
    Thromb Haemost; 1997 Feb; 77(2):270-7. PubMed ID: 9157580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Bajaj T; Fazlollah T; Szlam F; Wilson E; Kaiser A; Tosone SR; Miller BE
    Anesth Analg; 2008 Feb; 106(2):419-25, table of contents. PubMed ID: 18227295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
    Noguchi M; Eishi K; Tada S; Yamachika S; Hazama S; Izumi K; Tanigawa K
    Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo comparison study of FDA-approved surface-modifying additives and poly-2-methoxyethylacrylate circuit surfaces coatings during cardiopulmonary bypass.
    Ask A; Holt D; Smith L
    J Extra Corpor Technol; 2006 Mar; 38(1):27-32. PubMed ID: 16637520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits.
    Borowiec J; Bagge L; Saldeen T; Thelin S
    Thorac Cardiovasc Surg; 1997 Aug; 45(4):163-7. PubMed ID: 9323816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An experimental study of a newly developed silicone coated membrane oxygenator].
    Iida M
    Nihon Kyobu Geka Gakkai Zasshi; 1997 May; 45(5):700-10. PubMed ID: 9170861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system.
    Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Larsson LE; Ouchterlony J
    Ann Thorac Surg; 2004 Mar; 77(3):962-7. PubMed ID: 14992907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avecor Trillium oxygenator versus noncoated Monolyth oxygenator: a prospective randomized controlled study.
    Vanden Eynden F; Carrier M; Ouellet S; Demers P; Forcillo J; Perrault LP; Pellerin M; Bouchard D
    J Card Surg; 2008; 23(4):288-93. PubMed ID: 18598318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
    Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
    Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
    Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
    Nakahira A; Sasaki Y; Hirai H; Fukui T; Matsuo M; Takahashi Y; Kotani S; Suehiro S
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):555-60. PubMed ID: 20061337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients.
    Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A
    Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activation.
    Koster A; Fischer T; Gruendel M; Mappes A; Kuebler WM; Bauer M; Kuppe H
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):171-5. PubMed ID: 12698397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of Trillium Biopassive Surface-coated oxygenator versus uncoated oxygenator during cardiopulmonary bypass.
    Ereth MH; Nuttall GA; Clarke SH; Dearani JA; Fiechtner BK; Rishavy CR; Buda DA; Shaw TA; Orszulak TA; Oliver WC
    J Cardiothorac Vasc Anesth; 2001 Oct; 15(5):545-50; discussion 539-41. PubMed ID: 11687991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active or passive bio-coating: does it matters in extracorporeal circulation?
    Jacobs S; De Somer F; Vandenplas G; Van Belleghem Y; Taeymans Y; Van Nooten G
    Perfusion; 2011 Nov; 26(6):496-502. PubMed ID: 21719530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.